Clinical trial
Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
NCT02240381
Study timeline
Study start (actual)2014-11-20Date precision: day
Registry last updated2019-07-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitusunresolved
Malignant Neoplasmunresolved
Interventions
Sponsors & collaborators
Vanderbilt-Ingram Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02240381 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.